Clinical Trial Update: Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated tamoxifen citrate or letrozole with or without bevacizumab in women with stage IIIB or stage IV breast cancer; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Letrozole (letrozole)
• Tamoxifen citrate (tamoxifen citrate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Invasive Breast Carcinoma, Recurrent Breast Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2016-08-23